CLINICAL_TRIALS
trial_result
· 2008-11-11
Clinical Trial Update: A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients [Phase 1]
Summary
A completed Phase I trial evaluating the combination of bevacizumab and sunitinib in patients with metastatic renal cell carcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Metastatic Renal Cell Carcinoma, Kidney Cancer | Phase 1 | Status: COMPLETED